The global Isothermal Nucleic Acid Amplification Technology (INAAT) market size is predicted to grow from US$ 7499 million in 2025 to US$ 12600 million in 2031; it is expected to grow at a CAGR of 9.0% from 2025 to 2031.
The isothermal nucleic acid amplification technology (INAAT) is used in molecular biology and recombinant DNA technologies for detecting and identifying nucleic acids. It is commonly used to amplify nucleic acids at a constant temperature, thereby eliminating the need for thermocycler equipment. Isothermal amplification of nucleic acids is a simple process that rapidly and efficiently accumulates nucleic acid sequences at constant temperature.
Market Driver:
The Isothermal Nucleic Acid Amplification Technology (INAAT) market is driven by the growing demand for rapid and accurate diagnostic tools for infectious diseases, genetic disorders, and cancer. INAAT's ability to deliver high sensitivity and specificity without the need for complex thermal cycling equipment makes it ideal for point-of-care testing and use in resource-limited settings. Additionally, the rise in global health concerns, such as pandemics, has increased the adoption of INAAT for quick and reliable pathogen detection.
Market Challenge:
A significant challenge in the INAAT market is the high cost of specialized reagents and kits, which can limit accessibility in developing regions. The technology's complexity and the need for skilled personnel to interpret results may hinder widespread adoption in low-resource settings. Moreover, competition from established technologies like PCR and emerging alternatives creates pressure for differentiation and cost-effectiveness.
Industry Trends:
The INAAT industry is witnessing advancements in portable and user-friendly diagnostic devices, enabling real-time testing in non-laboratory environments. Integration with microfluidics and smartphone-based detection systems is enhancing accessibility and convenience. There is also a growing focus on multiplex INAAT assays capable of detecting multiple targets simultaneously, increasing diagnostic efficiency. Collaborations between biotech firms and healthcare organizations are fostering innovation and expanding the application of INAAT in personalized medicine and global health initiatives.
Global key players of Isothermal Nucleic Acid Amplification Technology (INAAT) include Abbott, BioMerieux and Hologic, etc. Global top three manufacturers hold a share over 70%. North America is the largest market of Isothermal Nucleic Acid Amplification Technology (INAAT), with a share nearly 80%, followed by Europe.
The 鈥淚sothermal Nucleic Acid Amplification Technology (INAAT) Industry Forecast鈥� looks at past sales and reviews total world Isothermal Nucleic Acid Amplification Technology (INAAT) sales in 2024, providing a comprehensive analysis by region and market sector of projected Isothermal Nucleic Acid Amplification Technology (INAAT) sales for 2025 through 2031. With Isothermal Nucleic Acid Amplification Technology (INAAT) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Isothermal Nucleic Acid Amplification Technology (INAAT) industry.
This Insight Report provides a comprehensive analysis of the global Isothermal Nucleic Acid Amplification Technology (INAAT) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Isothermal Nucleic Acid Amplification Technology (INAAT) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Isothermal Nucleic Acid Amplification Technology (INAAT) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Isothermal Nucleic Acid Amplification Technology (INAAT) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Isothermal Nucleic Acid Amplification Technology (INAAT).
This report presents a comprehensive overview, market shares, and growth opportunities of Isothermal Nucleic Acid Amplification Technology (INAAT) market by product type, application, key players and key regions and countries.
Segmentation by Type:
LAMP
TMA
NEAR
NASBA
HDA
SPIA
Other
Segmentation by Application:
Medical Diagnostic
Scientific Research
Food Testing
Environmental Hygiene
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
BioMerieux
Hologic
BD
Grifols
Quidel
Meridian Bioscience
Qiagen
Eiken Chemical
OptiGene
HiberGene Diagnostic
Lucigen
Nippon Gene
Mast Group
New England Biolabs
Ustar Biotechnologies
Thermo Fisher Scientific
MeG Biotech
BioLabs
Mast Group
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2020-2031)
2.1.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Country/Region (2020, 2024 & 2031)
2.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Segment by Type
2.2.1 LAMP
2.2.2 TMA
2.2.3 NEAR
2.2.4 NASBA
2.2.5 HDA
2.2.6 SPIA
2.2.7 Other
2.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type
2.3.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share by Type (2020-2025)
2.4 Isothermal Nucleic Acid Amplification Technology (INAAT) Segment by Application
2.4.1 Medical Diagnostic
2.4.2 Scientific Research
2.4.3 Food Testing
2.4.4 Environmental Hygiene
2.4.5 Other
2.5 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application
2.5.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share by Application (2020-2025)
3 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Player
3.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Market Share by Player
3.1.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Player (2020-2025)
3.1.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Player (2020-2025)
3.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Isothermal Nucleic Acid Amplification Technology (INAAT) by Region
4.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2020-2025)
4.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth (2020-2025)
4.4 APAC Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth (2020-2025)
4.5 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth (2020-2025)
4.6 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth (2020-2025)
5 Americas
5.1 Americas Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2020-2025)
5.2 Americas Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2020-2025)
5.3 Americas Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2020-2025)
6.2 APAC Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2020-2025)
6.3 APAC Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2020-2025)
7.2 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2020-2025)
7.3 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) by Region (2020-2025)
8.2 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2020-2025)
8.3 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Forecast
10.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast by Region (2026-2031)
10.1.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast by Region (2026-2031)
10.1.2 Americas Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.1.3 APAC Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.1.4 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.1.5 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.2 Americas Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast by Country (2026-2031)
10.2.1 United States Market Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.2.2 Canada Market Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.2.3 Mexico Market Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.2.4 Brazil Market Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.3 APAC Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast by Region (2026-2031)
10.3.1 China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Forecast
10.3.2 Japan Market Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.3.3 Korea Market Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.3.4 Southeast Asia Market Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.3.5 India Market Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.3.6 Australia Market Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.4 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast by Country (2026-2031)
10.4.1 Germany Market Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.4.2 France Market Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.4.3 UK Market Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.4.4 Italy Market Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.4.5 Russia Market Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.5 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast by Region (2026-2031)
10.5.1 Egypt Market Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.5.2 South Africa Market Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.5.3 Israel Market Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.5.4 Turkey Market Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
10.6 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast by Type (2026-2031)
10.7 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast
11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
11.1.3 Abbott Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 BioMerieux
11.2.1 BioMerieux Company Information
11.2.2 BioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
11.2.3 BioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 BioMerieux Main Business Overview
11.2.5 BioMerieux Latest Developments
11.3 Hologic
11.3.1 Hologic Company Information
11.3.2 Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
11.3.3 Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Hologic Main Business Overview
11.3.5 Hologic Latest Developments
11.4 BD
11.4.1 BD Company Information
11.4.2 BD Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
11.4.3 BD Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 BD Main Business Overview
11.4.5 BD Latest Developments
11.5 Grifols
11.5.1 Grifols Company Information
11.5.2 Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
11.5.3 Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Grifols Main Business Overview
11.5.5 Grifols Latest Developments
11.6 Quidel
11.6.1 Quidel Company Information
11.6.2 Quidel Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
11.6.3 Quidel Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Quidel Main Business Overview
11.6.5 Quidel Latest Developments
11.7 Meridian Bioscience
11.7.1 Meridian Bioscience Company Information
11.7.2 Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
11.7.3 Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Meridian Bioscience Main Business Overview
11.7.5 Meridian Bioscience Latest Developments
11.8 Qiagen
11.8.1 Qiagen Company Information
11.8.2 Qiagen Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
11.8.3 Qiagen Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Qiagen Main Business Overview
11.8.5 Qiagen Latest Developments
11.9 Eiken Chemical
11.9.1 Eiken Chemical Company Information
11.9.2 Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
11.9.3 Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Eiken Chemical Main Business Overview
11.9.5 Eiken Chemical Latest Developments
11.10 OptiGene
11.10.1 OptiGene Company Information
11.10.2 OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
11.10.3 OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 OptiGene Main Business Overview
11.10.5 OptiGene Latest Developments
11.11 HiberGene Diagnostic
11.11.1 HiberGene Diagnostic Company Information
11.11.2 HiberGene Diagnostic Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
11.11.3 HiberGene Diagnostic Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 HiberGene Diagnostic Main Business Overview
11.11.5 HiberGene Diagnostic Latest Developments
11.12 Lucigen
11.12.1 Lucigen Company Information
11.12.2 Lucigen Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
11.12.3 Lucigen Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Lucigen Main Business Overview
11.12.5 Lucigen Latest Developments
11.13 Nippon Gene
11.13.1 Nippon Gene Company Information
11.13.2 Nippon Gene Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
11.13.3 Nippon Gene Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Nippon Gene Main Business Overview
11.13.5 Nippon Gene Latest Developments
11.14 Mast Group
11.14.1 Mast Group Company Information
11.14.2 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
11.14.3 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Mast Group Main Business Overview
11.14.5 Mast Group Latest Developments
11.15 New England Biolabs
11.15.1 New England Biolabs Company Information
11.15.2 New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
11.15.3 New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 New England Biolabs Main Business Overview
11.15.5 New England Biolabs Latest Developments
11.16 Ustar Biotechnologies
11.16.1 Ustar Biotechnologies Company Information
11.16.2 Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
11.16.3 Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Ustar Biotechnologies Main Business Overview
11.16.5 Ustar Biotechnologies Latest Developments
11.17 Thermo Fisher Scientific
11.17.1 Thermo Fisher Scientific Company Information
11.17.2 Thermo Fisher Scientific Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
11.17.3 Thermo Fisher Scientific Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Thermo Fisher Scientific Main Business Overview
11.17.5 Thermo Fisher Scientific Latest Developments
11.18 MeG Biotech
11.18.1 MeG Biotech Company Information
11.18.2 MeG Biotech Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
11.18.3 MeG Biotech Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 MeG Biotech Main Business Overview
11.18.5 MeG Biotech Latest Developments
11.19 BioLabs
11.19.1 BioLabs Company Information
11.19.2 BioLabs Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
11.19.3 BioLabs Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 BioLabs Main Business Overview
11.19.5 BioLabs Latest Developments
11.20 Mast Group
11.20.1 Mast Group Company Information
11.20.2 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Product Offered
11.20.3 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Mast Group Main Business Overview
11.20.5 Mast Group Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
